In IFN-α-treated glioma cells, IFN-α considerably repressed the viability, migratory ability, and invasive ability of glioma cells, whereas CYBRD1 overexpression attenuated the effects of IFN-α treatment on glioma cell aggressiveness. Here, CYBRD1 is linked to glioma.